NEW YORK (360Dx) – Scoresby, Australia-based Sienna Cancer Diagnostics said today that it has entered an agreement that retains Axlab as its exclusive distribution partner for Denmark and Sweden.

The distribution agreement will broaden and accelerate the global roll out of its in-vitro diagnostic test, Sienna said. Under the terms of the agreement, Vedbaek, Denmark-based Axlab will sell Sienna’s product to pathology laboratories.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.